Earnings Call · Q2 FY2025·2025-08-01

Q2 25EPS +100.00%*·Rev n/aQ1 25EPS +78.26%·Rev n/aQ4 24EPS +22.65%·Rev n/aQ3 24EPS -90.32%·Rev n/a⚠ consensus missing

Indivior Pharmaceuticals, Inc. INDV

Jason Thompson — Host

Joseph J. Ciaffoni — Chief Executive Officer

Patrick A. Barry — Chief Commercial Officer

Ryan Preblick — Chief Financial Officer

+16.1%1d on move date+16.5% vs SPY3d+22.0%5d+26.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more INDV calls or request research access.

More INDV calls Browse calls Request research access